| Filed On | Filing |
|---|---|
| 21 Oct 2026 |
8-K: Regulation FD Disclosure
BURLINGTON, N.C., October 21, 2026 - Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of co... |
| 30 Sep 2026 |
8-K: Regulation FD Disclosure
BURLINGTON, N.C., (Sept. 30, 2026) – Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2026 before the market opens on Wedne... |
| 22 Sep 2026 |
8-K: Regulation FD Disclosure
On September 21, 2026, the Centers for Medicare & Medicaid Services (“CMS”) released preliminary Clinical Laboratory Fee Schedule payment rates applicable from 2027 through 2029 pursuant to the Protecting Access to Medicare Act (“PAMA”).... |
| 10 Sep 2026 |
8-K: Regulation FD Disclosure
2©2026 Labcorp. All rights reserved. Cautionary Statement Regarding Forward-Looking Statements This presentation contains forward-looking statements, including, but not limited to, statements with respect to (i) the estimated 2026 guidan... |
| 03 Sep 2026 |
Form 4: Oyegunwa Akinbolade, EVP, CIO & CTO
Granted 750 Restricted Stock Unit |
| 03 Sep 2026 |
Form 4: Meltzer Jonathan C, EVP, COO
Granted 900 Restricted Stock Unit |
| 03 Sep 2026 |
Form 4: Vaughn Bryan T, EVP and President, Diagnostics
Granted 1,500 Restricted Stock Unit |
| 03 Sep 2026 |
Form 4: Caveney Brian J, EVP, Pres of BLS, CMO & CSO
Granted 3,000 Restricted Stock Unit |
| 28 Aug 2026 | 8-K: Regulation FD Disclosure |
| 18 Aug 2026 |
Form 4: Anderson Kerrii B, Director
Sold 3,000 shares ($954K) |
| 17 Aug 2026 | 144 |
| 17 Aug 2026 | 8-K: Regulation FD Disclosure |
| 14 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 12 Aug 2026 |
Form 4: Schechter Adam H, Director
Sold 4,669 shares ($1.5M) |
| 11 Aug 2026 | 144 |
| 06 Aug 2026 |
Form 4: Summy Amy B., EVP, Chief Marketing Officer
Sold 924 shares ($283K) |
| 05 Aug 2026 |
Form 4: Wilkinson Peter J, SVP, Chief Accounting Officer
Sold 1,420 shares ($439K) · Received 1,338 shares by exercise or conversion ($280K) |
| 05 Aug 2026 | 10-Q |
| 04 Aug 2026 | 144 |
| 30 Jul 2026 | 8-K: Results of Operations and Financial Condition |
Loading...
